# Lipocalyx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lipocalyx

- Industry: Biotechnology
- Headquarters: Halle, Germany
- Website: www.lipocalyx.de
- Latest round: Seed (Sep 21, 2011)
- Investors on record: 2

## About

Lipocalyx specializes in innovative biopharmaceutical solutions, focusing on the development of delivery systems for therapeutic molecules to improve patient outcomes.Founded by Christian Reinsch and Steffen Panzner, Lipocalyx operates from Halle, Germany, and engages in developing advanced delivery systems for siRNA therapeutics. The company has undergone strategic pivots based on therapeutic advancements and has engaged in a funding round to fuel its development activities.The company primarily specializes in domain brokerage services, facilitating the buying and selling of internet domain names. Their core offerings include a secure platform for domain transactions, ensuring a transparent payment process and a smooth transfer of ownership once the payment is confirmed. This service caters to a diverse range of clients, including businesses and individuals looking to establish or enhance their online presence through unique and valuable domain names. The company emphasizes the importance of domain names as digital assets that hold varying degrees of value dependent on factors such as popularity, brevity, and industry relevance. Their target markets extend beyond their home region, serving clients in various global markets, including North America and Europe, who seek premium or established domain names to drive their business visibility and success.Revenue generation for the company is structured around transaction-based fees associated with the purchase of domain names. Upon initiating a purchase, clients are guided through a transparent payment process that includes options such as credit card, PayPal, or bank transfer. Each transaction involves a one-time purchase price with no hidden fees, and ongoing domain fees apply only after the domain transfer is completed. The company's business model emphasizes direct sales to end-users, predominantly through B2B transactions, where businesses acquire domain names to bolster their online branding and visibility. The broker operates with a fiduciary responsibility, ensuring that payment is secured before transferring domain ownership, thereby fostering trust and reliability within their client relationships.In September 2011, Lipocalyx raised an undisclosed amount of venture funding from High-Tech Gründerfonds and BMP. The company will use the funding to start its development activities in the field of siRNA delivery. Looking ahead, Lipocalyx aims to expand into new markets across North America and Europe, pursuing strategic partnerships and product launches aimed at enhancing their therapeutic capabilities.

## Funding rounds

- Seed, Sep 21, 2011 — BMP, High-Tech Gruenderfonds

## Investors

- BMP (https://capitalatlas.ai/funds/bmp) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed